An Engineered Biomimetic Nanoreactor With Cascade Functions for Targeted and Combinatorial Therapy of Ischemic Stroke
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Shaofa Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Youjiang Medical University For Nationalities Affiliated Southwest Hospital, Baise People's Hospital, Guangxi, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Biomimetic Materials, Nanoparticles. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Special Project of the Guangxi Natural Science Foundation, Youjiang Medical University for Nationalities Special Project, Self-funded Research Project of the Guangxi Health Commission.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke reperfusion injury is driven by oxidative stress and neuroinflammation, but current neuroprotective strategies suffer from poor targeting, limited functionality, and low blood‑‐brain barrier (BBB) penetration. Herein, a multifunctional nanoplatform (RM@HPAN) is constructed: a hollow mesoporous Prussian blue core with multi‑enzyme mimetic activity, loaded with L‑arginine and butylphthalide, cloaked with red blood cell membrane for immune evasion, and modified with RVG‑29 for brain targeting. RM@HPAN exhibits ideal nanosize, pH‑responsive release, and robust ROS scavenging. It crosses a BBB model in vitro and boosts neuronal viability under oxygen‑‐glucose deprivation/reoxygenation. In a mouse middle cerebral artery occlusion model, RM@HPAN targets ischemic regions, reduces infarct volume from 29.4% to 3.8%, improves neurological scores, and rebalances inflammatory cytokines (TNF‑α, IL‑6, IL‑10, TGF‑β1). Transcriptomic and proteomic analyses reveal that RM@HPAN suppresses cytokine‑cytokine receptor interaction and TNF signaling while activating Rap1/PI3K/Akt and Nrf2/HO‑1 pathways, thereby inhibiting apoptosis and oxidative stress. Biosafety assessments confirm good biocompatibility. Thus, RM@HPAN offers a promising translatable strategy for ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Youjiang Medical University For Nationalities Affiliated Southwest Hospital, Baise People's Hospital, Guangxi, China.
- Department of Neurology, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
- Nanning Second People's Hospital Neurology Department, Guangxi, China.
Förderung
- Joint Special Project of the Guangxi Natural Science Foundation
- Youjiang Medical University for Nationalities Special Project
- Self-funded Research Project of the Guangxi Health Commission
Zitieren
APA
Li, S., Wu, Y., Wei, H., Teng, J., Yang, Z., Chen, J., Liao, B., Huang, X., Meng, L., & Li, T. (2026). An Engineered Biomimetic Nanoreactor With Cascade Functions for Targeted and Combinatorial Therapy of Ischemic Stroke. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71712
Vancouver
Li S, Wu Y, Wei H, Teng J, Yang Z, Chen J, et al. An Engineered Biomimetic Nanoreactor With Cascade Functions for Targeted and Combinatorial Therapy of Ischemic Stroke. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71712
BibTeX
@article{Li2026,
author = {Li, Shaofa and Wu, Ying and Wei, Huimin and Teng, Jinyong and Yang, Zaizhi and Chen, Jufang and Liao, Bao and Huang, Xiaoqin and Meng, Lanqing and Li, Tong},
title = {An Engineered Biomimetic Nanoreactor With Cascade Functions for Targeted and Combinatorial Therapy of Ischemic Stroke},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71712}
}
EUVIMED